Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 9.15
-0.10 (-1.06%)
At close: Mar 18, 2026
Grifols Revenue
In the year 2025, Grifols had annual revenue of 1.23B EUR, down -79.02%.
Revenue
1.23B
Revenue Growth
-79.02%
P/S Ratio
0.75
Revenue / Employee
297.89K
Employees
25,258
Market Cap
5.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.23B | -4.63B | -79.02% |
| Dec 31, 2022 | 5.86B | 517.88M | 9.70% |
| Dec 31, 2020 | 5.34B | 241.35M | 4.73% |
| Dec 31, 2019 | 5.10B | 2.36B | 85.97% |
| Dec 31, 2013 | 2.74B | 120.79M | 4.61% |
| Dec 31, 2012 | 2.62B | 1.63B | 164.55% |
| Dec 31, 2010 | 990.73M | 77.54M | 8.49% |
| Dec 31, 2009 | 913.19M | 98.88M | 12.14% |
| Dec 31, 2008 | 814.31M | 111.02M | 15.79% |
| Dec 31, 2007 | 703.29M | 54.87M | 8.46% |
| Dec 31, 2006 | 648.42M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Almirall | 1.11B |
| Laboratorios Farmaceuticos Rovi | 743.48M |
| Faes Farma | 626.99M |
| Laboratorio Reig Jofre | 336.68M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 240.68M |
| Atrys Health | 226.24M |
| Pharma Mar | 221.39M |
Grifols News
- 1 day ago - Grifols (GRFS) Reveals Advancements in Early Parkinson's Detection - GuruFocus
- 1 day ago - Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease - GlobeNewsWire
- 5 days ago - Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance - Benzinga
- 5 days ago - Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance - GlobeNewsWire
- 6 days ago - Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites - GlobeNewsWire
- 20 days ago - Grifols SA (GRFS) (Full Year 2025) Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus
- 20 days ago - Full Year 2025 Grifols SA Earnings Call Transcript - GuruFocus
- 20 days ago - Grifols (GRFS) Projects Strong Financial Performance by 2026 - GuruFocus